Richard J Wurtman

This inventor holds 69 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Neurological Disorders (CPC class 514 ). Top assignees: Massachusetts Institute of Technology, Interneuron Pharmaceuticals, Inc., Back Bay Scientific, LLC. Active years: 1980-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard J Wurtman. Retrieved from https://idiyas.com/inventor/richard-j-wurtman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 69 (Patent Applications = 2)

% Patents Active = 95.7

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 1.6

ph-index = 16

Forward Citations = 849(Granted Patents)

Forward Citations (Not Self Cited) = 775(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Waban, MA (US) (1980 - 1983)
Boston, MA (US) (1981 - 2020)

Company Filing History:

62 out of 8,594

Massachusetts Institute of Technology

patents

5 out of 15

Interneuron Pharmaceuticals, Inc.

patents

1 out of 1

Back Bay Scientific, LLC

patent

4. 1 out of 834,570

Other

patents

Years Active: 1980-2020

Loading Chart...

Areas of Expertise:

PUFA

Uridine

Synaptogenesis

Cognitive Function

Neurological Disorders

Neurodegenerative Diseases

Dopamine Release

Weight Loss

Memory Improvement

Estrogenic Compound

Amyloid Precursor Protein

Melatonin

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10736912 - Compositions containing PUFA and/or uridine and methods of use thereof (2020-08-11),

2. 10525071 - Compositions containing PUFA and methods of use thereof (2020-01-07),

3. 10086009 - Compositions containing pufa and/or uridine and methods of use thereof (2018-10-02),

4. 9572830 - Uridine effects on dopamine release (2017-02-21),

5. 8691775 - Use of drugs that activate P2Y receptors to enhance synaptogenesis (2014-04-08),

6. 8551452 - Uridine dietary supplementation compliance methods and use thereof (2013-10-08),

7. 8518882 - Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same (2013-08-27),

8. 8314064 - Uridine administration stimulates membrane production (2012-11-20),

9. 8143234 - Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function (2012-03-27),

10. 7011857 - Weight loss compositions and methods for individuals who may have gastric hyperacidity (2006-03-14),

11. 6989376 - Methods for increasing blood cytidine and/or uridine levels and treating cytidine-dependent human diseases (2006-01-24),

12. 6579899 - Composition for treatment of stress (2003-06-17),

13. 6469055 - Compositions and methods for treatment of neurological disorders and neurodegenerative diseases (2002-10-22),

14. 6333317 - Regulation of amyloid precursor protein (APP) expression by administration of an estrogenic compound (2001-12-25),

15. 6329155 - Methods of identifying agents which regulate release of amyloid precursor protein (2001-12-11),

Certainly. Here is the article about inventor Richard J. Wurtman:

Title: Unveiling the Inventive Mind of Richard J. Wurtman

Introduction:

Richard J. Wurtman, a distinguished inventor hailing from Boston, MA, has made significant contributions to the field of brain development and cognitive enhancement. With an impressive portfolio of 69 patents, Wurtman's innovative creations have revolutionized the way we perceive intelligence and neurological health.

Latest Patents:

Wurtman's recent patents include groundbreaking inventions such as "Compositions containing PUFA and/or uridine and methods of use thereof," which focus on enhancing brain development and treating memory disorders using omega-3 fatty acids, omega-6 fatty acids, and uridine. These methods have the potential to elevate the synthesis of phospholipids, synapses, and synaptic proteins in neural cells, paving the way for a new era of cognitive enhancement.

Career Highlights:

Having worked at esteemed institutions like the Massachusetts Institute of Technology and Interneuron Pharmaceuticals, Inc., Wurtman has showcased his prowess in bridging the gap between scientific research and real-world applications. His dedication to advancing the frontiers of neuroscience has earned him a well-deserved reputation as a trailblazer in the field.

Collaborations:

Throughout his career, Wurtman has collaborated with top minds in the industry, including Judith J. Wurtman and John H. Growdon. Together, they have spearheaded research projects that have laid the foundation for future breakthroughs in cognitive science and neurological health.

Conclusion:

In conclusion, Richard J. Wurtman's unwavering commitment to innovation and his relentless pursuit of scientific excellence have cemented his legacy as a visionary inventor in the realm of brain development and cognitive enhancement. His patents stand as a testament to his groundbreaking work and serve as an inspiration for future generations of inventors seeking to make a positive impact on the world.

Profile summary based on public USPTO records.